Indaptus Therapeutics (INDP) Shares Outstanding (Diluted) (2022 - 2026)
Indaptus Therapeutics (INDP) posted Shares Outstanding (Diluted) of 64.11 million for Q2 2026, compared with 574,923 a year earlier and up 485.1% from the prior quarter.
Powered by 
Analysis
Indaptus Therapeutics (INDP) Shares Outstanding (Diluted) (2022 - 2026) Analysis & Trends
For FY2025, Indaptus Therapeutics' Shares Outstanding (Diluted) came in at 966,124, up 189.2% from FY2024.
- Annual Shares Outstanding (Diluted) has increased for three consecutive years, with a three-year compound annual growth rate of 48.5% (FY2022 to FY2025).
- In prior years, Indaptus Therapeutics' Shares Outstanding (Diluted) was 334,092 in FY2024 (+11.4%), 300,001 in FY2023 (+1.7%) and 295,040 in FY2022.
- The Q2 2026 figure stands as the highest quarterly Shares Outstanding (Diluted) in data going back to Q2 2022.
- The year-over-year growth in Shares Outstanding (Diluted) has ranged between 0.5% (Q1 2024) and 193.6% (Q3 2025) over the last five years.
- According to Business Quant data, Shares Outstanding (Diluted) for the three prior quarters was 10.96 million (Q1 2026), 966,124 (Q4 2025) and 997,038 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Indaptus Therapeutics | 147.46 Mn | 120.07 Mn | - | 64.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 64.11 Mn |
| Mar 31, 2026 | 10.96 Mn |
| Dec 31, 2025 | 966,124.00 |
| Sep 30, 2025 | 997,038.00 |
| Jun 30, 2025 | 574,923.00 |
| Mar 31, 2025 | 503,596.00 |
| Dec 31, 2024 | 334,092.00 |
| Sep 30, 2024 | 339,618.00 |
| Jun 30, 2024 | 305,103.00 |
| Mar 31, 2024 | 301,477.00 |
| Dec 31, 2023 | 300,001.00 |
| Sep 30, 2023 | 300,001.00 |
| Jun 30, 2023 | 300,001.00 |
| Mar 31, 2023 | 300,001.00 |
| Dec 31, 2022 | 295,040.00 |
| Sep 30, 2022 | 294,914.00 |
| Jun 30, 2022 | 294,914.00 |
API Access
Indaptus Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=INDP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "INDP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=INDP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();